Presenter Status
Fellow
Abstract Type
Research
Primary Mentor
Bruno Hagenbuch, PhD
Start Date
16-5-2025 12:30 PM
End Date
16-5-2025 12:45 PM
Presentation Type
Oral Presentation
Description
This project characterizes the role of OCT1 and OCT2 on cellular uptake of atenolol and tests the hypothesis that OCT1 and OCT2 proteins with genetic polymorphisms, when expressed in vitro, will result in altered cellular uptake of atenolol relative to the reference genotype. This approach utilizes transiently transfected OCT1 and OCT2 cell assays to perform time-dependent atenolol uptake experiments to generate kinetics information. The goal is to provide a better understanding of polymorphisms associated with OCT1 and OCT2 expression and function as a means to individualize pharmacologic therapy for atenolol.
Included in
Cardiology Commons, Chemical and Pharmacologic Phenomena Commons, Medical Pharmacology Commons
Effects of Genetic Polymorphisms on the OCT1 and OCT2-Mediated Uptake of Atenolol
This project characterizes the role of OCT1 and OCT2 on cellular uptake of atenolol and tests the hypothesis that OCT1 and OCT2 proteins with genetic polymorphisms, when expressed in vitro, will result in altered cellular uptake of atenolol relative to the reference genotype. This approach utilizes transiently transfected OCT1 and OCT2 cell assays to perform time-dependent atenolol uptake experiments to generate kinetics information. The goal is to provide a better understanding of polymorphisms associated with OCT1 and OCT2 expression and function as a means to individualize pharmacologic therapy for atenolol.
